ConductScience.org, home

Paper41969646

Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery.

Wu Y and 9 others. Bioact Mater, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery. Papers, record 41969646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41969646

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery.
PubMed
Journal
Bioact Mater
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu YYayun
2Zhang WWeinan
3Jiang YYechun
4Fu WWanyue
5Zha YYutao
6Liu NNian
7Fang MMing
8Chu ZZhaoyou
9Shao MMin
10Qian HHaisheng

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References190

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140471243Advancing pulmonary therapy: the role of dry powder inhalation technology in lung disease management.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40471243PubMed
232540976Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32540976PubMed
335112802
Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery.
Adv Healthc Mater2022https://conductscience.org/library/papers/35112802PubMed
438181690APTES-mediated Cu2(OH)3(NO3) nanomaterials on the surface of silicone catheters for abscess.Colloids Surf B Biointerfaces2024https://conductscience.org/library/papers/38181690PubMed
539469425Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles.J Pharm Pharm Sci2024https://conductscience.org/library/papers/39469425PubMed
637657277Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation.Biomater Adv2023https://conductscience.org/library/papers/37657277PubMed
737214258Intrinsically bioactive and biomimetic nanoparticle-derived therapies alleviate asthma by regulating multiple pathological cells.Bioact Mater2023https://conductscience.org/library/papers/37214258PubMed
838708178Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road?Int J Nanomedicine2024https://conductscience.org/library/papers/38708178PubMed
937622289Wet-adhesive γ-PGA/ε-PLL hydrogel loaded with EGF for tracheal epithelial injury repair.J Mater Chem B2023https://conductscience.org/library/papers/37622289PubMed
1027418577Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Clin Infect Dis2016https://conductscience.org/library/papers/27418577PubMed
1138711938A multifunctional ionic liquid coating on 3D-Printed prostheses: Combating infection, promoting osseointegration.Mater Today Bio2024https://conductscience.org/library/papers/38711938PubMed
1238699242Macrophage based drug delivery: Key challenges and strategies.Bioact Mater2024https://conductscience.org/library/papers/38699242PubMed
1335513402Microwave assisted antibacterial action of Garcinia nanoparticles on Gram-negative bacteria.Nat Commun2022https://conductscience.org/library/papers/35513402PubMed
1434015383Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review.J Infect2021https://conductscience.org/library/papers/34015383PubMed
1541282407An inhalable gallium-polyphenol nanoparticle blocks bacterial electron transport chain and signal transduction for anti-biofilm therapy.Bioact Mater2026https://conductscience.org/library/papers/41282407PubMed
1638698403Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis.BMC Pulm Med2024https://conductscience.org/library/papers/38698403PubMed
1739061312In Vitro Evaluation of Colistin Conjugated with Chitosan-Capped Gold Nanoparticles as a Possible Formulation Applied in a Metered-Dose Inhaler.Antibiotics (Basel)2024https://conductscience.org/library/papers/39061312PubMed
1834332109Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics.Clin Microbiol Infect2022https://conductscience.org/library/papers/34332109PubMed
1939737874Multifaceted Immunomodulatory Nanocomplexes Target Neutrophilic-ROS Inflammation in Acute Lung Injury.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39737874PubMed
2031898875Polymyxin B-Polysaccharide Polyion Nanocomplex with Improved Biocompatibility and Unaffected Antibacterial Activity for Acute Lung Infection Management.Adv Healthc Mater2020https://conductscience.org/library/papers/31898875PubMed

See all 190 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42667161A Huaxian Formula Nanoformulation Confers Protection Against Acute Radiation-Induced Lung Injury by Targeting Ferroptosis.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42667161

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41969646

GET https://conductscience.org/api/papers/v1/41969646/references?page=2